Biotech

The biotech and medtech sectors are dynamic, capital-intensive, and increasingly intertwined with innovation cycles that can be difficult to time. At Turk & Co., we help founders, executives, and investors make strategic decisions with clarity—whether they’re raising capital, pursuing an exit, or evaluating strategic partnerships.

Our experience spans early-stage ventures, growth-phase innovators, and mature businesses across diagnostics, medical devices, life sciences tools, and health technology platforms.

Led by Edward McKenna, PhD, our biotech advisory practice brings together deep technical knowledge and real-world deal experience. With a background that spans product development, corporate strategy, and commercialization, Dr. McKenna has advised companies from startup to scale-up to exit.

We understand what drives value in this space: IP strength, regulatory clarity, clinical differentiation, and commercial potential. Our team speaks the language of science and business—bridging the gap between innovation and capital.

We support clients through:

• Sell-side and buy-side M&A

• Capital raises and recapitalizations

• Strategic growth planning

• Partnering and licensing strategy

• Corporate development execution

Whether you’re looking to position for acquisition, secure strategic investment, or carve a new path in the market, Turk & Co. brings the focus, insight, and execution expertise to help you move forward.